About: covid:5d3dce397b54b88e25b7fb4901d5ace5f1856342

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: covid:5d3dce397b54b88e25b7fb4901d5ace5f1856342 Goto Sponge NotDistinct Permalink

An Entity of Type : owl:Thing, within Data Space : wasabi.inria.fr associated with source document(s)

Attributes	Values
Creator	Nozzoli, Carlo Annunziato, Francesco Atanasio, Alessandro Bartoloni, Alessandro Bencini, Sara Berni, Andrea Capone, Manuela Chiara Paoli, • Falchetti, Giorgia Fanelli, Andrea Guglielmelli, Paola Loscocco, Giuseppe Luise, Fabio Maggi, Laura Malandrino, Danilo Marie, • Mazzoni, Alessio Millotti, Giovanni Miselli, Filippo Morettini, Alessandro Para, • Piccinni, Pierre Pieralli, Filippo Poggesi, Loredana Scotti, Valentina Sordi, Benedetta Tassinari, Irene Vannucchi, Alessandro Zammarchi, •
is schema:about of	named entity 'patients' named entity 'dose' named entity 'observational study' named entity 'intensity' named entity 'COVID-19' named entity 'imaging' named entity 'inhibitor' named entity 'FiO2' named entity 'supplemental oxygen' named entity 'cytotoxic' named entity 'Italian' named entity 'antimicrobials' named entity 'SARS-CoV-2' named entity 'oxygen' named entity '95% CI' named entity 'receptor' named entity 'bacterial sepsis' named entity 'IL-9' named entity 'pulmonary failure' named entity 'Anti-inflammatory' named entity 'allogeneic hematopoietic stem cell transplantation' named entity 'immune cell' named entity 'MCP1' named entity 'higher concentration' named entity 'mechanical ventilation' named entity 'SARS-CoV' named entity 'intracellular' named entity 'ruxolitinib' named entity 'COVID-19' named entity 'randomized trial' named entity 'oxygen' named entity 'ruxolitinib' named entity '28 days' named entity '0.51' named entity 'NK cells' named entity 'ruxolitinib' named entity 'ruxolitinib' named entity 'SARS-CoV-2' named entity 'monocytes' named entity 'treatment protocol' named entity 'diabetes' named entity 'viral shedding' named entity 'general health' named entity '28 days' named entity 'Solidarity Trial' named entity '95% CI' named entity 'Creative Commons Attribution 4.0' named entity '21 days' named entity 'oxygen support' named entity 'standard of care' named entity 'antiparasitic agents' named entity 'SARS-CoV-2' named entity 'tissue damage' named entity 'interferon gamma' named entity 'lopinavir' named entity 'refractory' named entity 'IFN-γ' named entity 'cytokine' named entity 'antiviral agents' named entity 'pneumonia' named entity 'CRP' named entity 'Common Terminology Criteria for Adverse Events' named entity 'placebo-controlled study' named entity 'mechanical ventilation' named entity 'COVID' named entity 'chronic heart disease' named entity 'hemoglobin' named entity 'ruxolitinib' named entity 'control subjects' named entity 'monocytes' named entity 'antiviral agents'

Attributes

Values

Creator

Nozzoli, Carlo
Annunziato, Francesco
Atanasio, Alessandro
Bartoloni, Alessandro
Bencini, Sara
Berni, Andrea
Capone, Manuela
Chiara Paoli, •
Falchetti, Giorgia
Fanelli, Andrea
Guglielmelli, Paola
Loscocco, Giuseppe
Luise, Fabio
Maggi, Laura
Malandrino, Danilo
Marie, •
Mazzoni, Alessio
Millotti, Giovanni
Miselli, Filippo
Morettini, Alessandro
Para, •
Piccinni, Pierre
Pieralli, Filippo
Poggesi, Loredana
Scotti, Valentina
Sordi, Benedetta
Tassinari, Irene
Vannucchi, Alessandro
Zammarchi, •

is schema:about of

Faceted Search & Find service v1.13.91 as of Mar 24 2020

Alternative Linked Data Documents: Sponger | ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software